Yarrow Bioscience, Inc.
YARW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566044
No open-market purchases or sales by Yarrow Bioscience, Inc. insiders were filed in the last 90 days; 46 institutions reported holding it in 13F filings for Q2 2026, worth $8.79M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Yarrow Bioscience, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +2 vs. Q2 2024
- Shares held
- 7.35M
- −569.1K (−7.2%) vs. Q2 2024
- Total value
- $14.3M
- −$1.66M (−10.4%) vs. Q2 2024
- New holders
- 3
- 4 more added
- Sold out
- 1
- 12 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting YARW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $8.79M |
| Q1 2026 | 46 | $8.49M |
| Q4 2025 | 45 | $5.35M |
| Q3 2025 | 36 | $1.33M |
| Q2 2025 | 46 | $13.4M |
| Q1 2025 | 38 | $11.5M |
| Q4 2024 | 35 | $23.4M |
| Q3 2024 | 33 | $14.3M |
| Q2 2024 | 32 | $16.1M |
| Q1 2024 | 32 | $22.9M |
| Q4 2023 | 33 | $18.4M |
| Q3 2023 | 21 | $1.54M |
| Q2 2023 | 20 | $1.63M |
| Q1 2023 | 23 | $1.10M |
| Q4 2022 | 41 | $1.10M |
| Q3 2022 | 41 | $1.84M |
| Q2 2022 | 41 | $3.25M |
| Q1 2022 | 45 | $5.63M |
| Q4 2021 | 55 | $12.5M |
| Q3 2021 | 65 | $20.1M |
| Q2 2021 | 73 | $64.0M |
| Q1 2021 | 87 | $152.4M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Yarrow Bioscience, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Eventide Asset Management, LLC | 1,394,336 | $3.13M | 0.05% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,394,336 | $2.62M | 0.14% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,187,413 | $2.23M | 0.00% | −23,653−2.0% | Reduced |
| DSC Advisors, L.P. | 696,465 | $1.31M | 11.93% | 00.0% | Unchanged |
| Palo Alto Investors LP | 445,434 | $837.4K | 0.11% | 00.0% | Unchanged |
| Vanguard Group Inc | 443,518 | $833.8K | 0.00% | 00.0% | Unchanged |
| Exome Asset Management LLC | 353,434 | $664.5K | 0.45% | 00.0% | Unchanged |
| AlphaCentric Advisors LLC | 268,485 | $504.8K | 0.38% | −42,015−13.5% | Reduced |
| Parkman Healthcare Partners LLC | 202,973 | $381.6K | 0.05% | −142,233−41.2% | Reduced |
| Schonfeld Strategic Advisors LLC | 168,600 | $317.0K | 0.00% | −47,623−22.0% | Reduced |
| ADAR1 Capital Management, LLC | 152,865 | $287.4K | 0.05% | −18,352−10.7% | Reduced |
| Geode Capital Management, LLC | 134,590 | $253.0K | 0.00% | −1,080−0.8% | Reduced |
| Renaissance Technologies LLC | 86,643 | $162.9K | 0.00% | +23,532+37.3% | Added |
| BlackRock, Inc. | 83,069 | $156.2K | 0.00% | +83,069 | New |
| Silverarc Capital Management, LLC | 76,784 | $144.4K | 0.03% | −390,613−83.6% | Reduced |
| Prelude Capital Management, LLC | 65,147 | $122.5K | 0.01% | +113+0.2% | Added |
| Susquehanna International Group, LLP | 60,356 | $113.5K | 0.00% | +33+0.1% | Added |
| Northern Trust Corp | 37,290 | $70.1K | 0.00% | −365−1.0% | Reduced |
| Staley Capital Advisers Inc | 36,472 | $68.6K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 18,298 | $34.0K | 0.00% | +18,298 | New |
| Lynx1 Capital Management LP | 16,194 | $30.4K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 15,765 | $29.6K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,440 | $5.00K | 0.00% | −2,016−45.2% | Reduced |
| Bank of America Corp | 2,278 | $4.28K | 0.00% | −28−1.2% | Reduced |
| Tower Research Capital LLC (TRC) | 2,209 | $4.15K | 0.00% | −1,174−34.7% | Reduced |
| Morgan Stanley | 1,799 | $3.38K | 0.00% | 00.0% | Unchanged |
| MB, Levis & Associates, LLC | 1,041 | $1.96K | 0.00% | 00.0% | Unchanged |
| Centerpoint Advisors, LLC | 350 | $1.00K | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 187 | $351 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 177 | $332 | 0.00% | +1+0.6% | Added |
| Barclays PLC | 100 | $188 | 0.00% | +100 | New |
| Wells Fargo & Company | 65 | $122 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 14 | $26 | 0.00% | −25,044−99.9% | Reduced |
| Ashton Thomas Private Wealth, LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |